The use of GnRHa alone as a trigger has been recommended for patients at risk of OHSS undergoing ovarian stimulation and prescribed GnRH antagonists to block the early LH surge (ORPI/BAND E). The gene discussed is PLOD1; the disease is ovarian hyperstimulation syndrome.